MLMCX Performance — Global Core Portfolio, Class C
Data updated: 2026-08-21
MLMCX returned +4.28% year to date and +13.86% over one year to Jun 2026. Annualised returns are +15.67% over 3 years and +7.84% over 5 years. The fund trailed its Global Large Blend category average: $100 invested three years ago grew to $155, against $156 for the category, and to $114 over one year, against $118. Volatility over the past three years was 14.14% a year. In the 12 months to Jun 2026 the fund took in a net $14.9M, and assets reached $65.22M.
MLMCX Growth of $100
What $100 invested in Global Core Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Global Large Blend category average over the same months.
| Period | MLMCX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $114 | $118 |
| 3 years (Jul 2023 – Jun 2026) | $155 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $146 | $149 |
| Since data start (Jul 2019 – Jun 2026) | $213 | $204 |
MLMCX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.28% |
| 1 year | +13.86% |
| 3 years (annualised) | +15.67% |
| 5 years (annualised) | +7.84% |
MLMCX Annual Returns
Calendar-year total returns of Global Core Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +4.28% |
| 2025 | +16.59% |
| 2024 | +22.62% |
| 2023 | +16.69% |
| 2022 | −20.24% |
| 2021 | +16.32% |
| 2020 | +19.90% |
| 2019 (Jul–Dec) | +10.10% |
MLMCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.0% | −1.0% | −7.0% | +9.8% | +2.3% | −0.1% | — | — | — | — | — | — |
| 2025 | +3.3% | −0.1% | −6.2% | −0.1% | +6.5% | +3.7% | +1.4% | +3.9% | +4.0% | −0.6% | −0.7% | +1.0% |
| 2024 | +2.5% | +7.9% | +3.3% | −4.7% | +4.8% | +2.0% | +0.3% | +3.5% | +0.5% | +0.1% | +4.8% | −3.8% |
| 2023 | +9.4% | −3.0% | −0.1% | +0.8% | −3.3% | +8.7% | +2.1% | −3.7% | −5.5% | −2.1% | +10.3% | +3.6% |
| 2022 | −5.1% | −4.6% | +0.1% | −6.8% | −0.9% | −8.6% | +9.6% | −4.3% | −8.9% | +4.0% | +9.6% | −4.2% |
| 2021 | +0.6% | +3.1% | 0.0% | +5.3% | +0.7% | +0.7% | +0.6% | +1.3% | −3.8% | +7.2% | −2.3% | +2.4% |
| 2020 | +0.1% | −8.3% | −15.7% | +10.2% | +6.2% | +4.3% | +7.8% | +7.7% | −2.6% | −0.7% | +8.9% | +4.0% |
| 2019 | — | — | — | — | — | — | +0.9% | −1.7% | +1.2% | +2.8% | +3.5% | +3.1% |
MLMCX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 14.14%
- 3-year Sharpe ratio: 0.79 (vs 4.5% risk-free rate)
- Best month: +10.30% (Nov 2023)
- Worst month: −6.99% (Mar 2026)
MLMCX Fund Flows
Monthly money in and out of Global Core Portfolio, from SEC Form N-PORT.
- 12-month net flow: $14.9M
- 12-month gross sales (incl. reinvestments): $24.3M
- Sales ÷ redemptions: 2.57×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.3M | $771K | $483K |
| May 2026 | $1.1M | $492K | $585K |
| Apr 2026 | $4.9M | $328K | $4.6M |
| Mar 2026 | $925K | $1.7M | −$771K |
| Feb 2026 | $2.2M | $565K | $1.7M |
| Jan 2026 | $1.4M | $342K | $1.1M |
| Dec 2025 | $2.7M | $838K | $1.9M |
| Nov 2025 | $2.3M | $655K | $1.6M |
| Oct 2025 | $2.5M | $1.8M | $755K |
| Sep 2025 | $2.3M | $507K | $1.8M |
| Aug 2025 | $2.0M | $461K | $1.5M |
| Jul 2025 | $625K | $1.0M | −$409K |
MLMCX Assets Under Management
Net assets of Global Core Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $65.22M |
| 2026-03-31 | $52.79M |
| 2025-12-31 | $54.73M |
| 2025-09-30 | $51.71M |
| 2025-06-30 | $44.31M |
| 2025-03-31 | $37.60M |
| 2024-12-31 | $36.77M |
| 2024-09-30 | $35.10M |
| 2024-06-30 | $32.57M |
| 2024-03-31 | $28.85M |
| 2023-12-31 | $23.91M |
| 2023-09-30 | $21.74M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.